Table S1.
Baseline systemic and ophthalmic variables of 96 eyes of 88 patients related to a visual outcome of less than 20/400
| Preoperative variable | Number of eyes (total n=96) |
Number of eyes with final visual acuity <20/400 (%) (total n=35) | Univariate |
|---|---|---|---|
| Age >50 years | 66 | 29 (43.9%) | P=0.024 |
| Age <50 years | 30 | 6 (20%) | |
| Type 1 diabetes | 18 | 4 (22.2%) | P=0.16 |
| Type 2 diabetes | 78 | 31 (39.7%) | |
| Diabetes >15 years | 63 | 19 (30%) | P=0.1 |
| Diabetes <15 years | 27 | 13 (48%) | |
| Visual acuity <20/400 | 61 | 31 (50.8%) | P<0.001 |
| Visual acuity ≥20/400 | 35 | 4 (11.4%) | |
| Preoperative laser | 75 | 28 (37%) | P=0.73 |
| No preoperative laser | 21 | 7 (33%) | |
| Preoperative avastin | 50 | 16 (32%) | P=0.34 |
| No preoperative avastin | 46 | 19 (41%) | |
| Ischemia | 54 | 30 (55%) | P<0.001 |
| No ischemia | 41 | 4 (9.8%) | |
| Phakic eye | 81 | 29 (35.8%) | P=0.75 |
| Pseudophakic eye | 15 | 6 (40%) | |
| Iris neovascularization | 6 | 2 (33%) | P=1 |
| No iris neovascularization | 90 | 33 (36.7%) | |
| Macula detached 6–12 months | 70 | 27 (38.6%) | P=0.48 |
| Macula detached >12 months | 26 | 8 (31%) | |
| Vitreous hemorrhage | 56 | 19 (34%) | P=0.54 |
| No vitreous hemorrhage | 40 | 16 (40%) | |
| Thick fibrovascular tissue | 37 | 15 (40%) | P=0.51 |
| No thick fibrovascular tissue | 59 | 20 (34%) |
Note: The values in bold were found to be statistically significant variables for the visual outcome.